On Monday, Rani Therapeutics Holdings Inc (NASDAQ: RANI) was -7.50% drop from the session before settling in for the closing price of $1.6. A 52-week range for RANI has been $0.39 – $3.87.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 4.78%. When this article was written, the company’s average yearly earnings per share was at 59.52%. With a float of $89.73 million, this company’s outstanding shares have now reached $97.55 million.
Rani Therapeutics Holdings Inc (RANI) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Rani Therapeutics Holdings Inc stocks. The insider ownership of Rani Therapeutics Holdings Inc is 8.02%, while institutional ownership is 16.13%. The most recent insider transaction that took place on Oct 23 ’25, was worth 1,260,417. In this transaction Director of this company bought 2,083,334 shares at a rate of $0.60, taking the stock ownership to the 2,083,334 shares. Before that another transaction happened on Oct 21 ’25, when Company’s 10% Owner sold 4,000,000 for $2.77, making the entire transaction worth $11,074,000. This insider now owns 2,379,194 shares in total.
Rani Therapeutics Holdings Inc (RANI) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.16 earnings per share (EPS) during the time that was better than consensus figure (set at -0.23) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 59.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 35.44% during the next five years compared to 4.78% growth over the previous five years of trading.
Rani Therapeutics Holdings Inc (NASDAQ: RANI) Trading Performance Indicators
You can see what Rani Therapeutics Holdings Inc (RANI) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.26. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 149.87.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.79, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.27 in one year’s time.
Technical Analysis of Rani Therapeutics Holdings Inc (RANI)
Compared to the last year’s volume of 5.77 million, its volume of 2.2 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 21.39%.
During the past 100 days, Rani Therapeutics Holdings Inc’s (RANI) raw stochastic average was set at 31.38%, which indicates a significant increase from 5.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1816 in the past 14 days, which was higher than the 0.1581 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3813, while its 200-day Moving Average is $0.9837. Nevertheless, the first resistance level for the watch stands at $1.5529 in the near term. At $1.6257, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.6822. If the price goes on to break the first support level at $1.4236, it is likely to go to the next support level at $1.3671. Now, if the price goes above the second support level, the third support stands at $1.2943.
Rani Therapeutics Holdings Inc (NASDAQ: RANI) Key Stats
There are 121,512K outstanding shares of the company, which has a market capitalization of 179.85 million. As of now, sales total 1,030 K while income totals -30,020 K. Its latest quarter income was 0 K while its last quarter net income were -6,690 K.
